Alpha 2.0
Login Register
» Articles » PMID: 29185196

ACMT Position Statement: Addressing the Rising Cost of Prescription Antidotes

Overview
Journal J Med Toxicol
Publisher Springer
Specialty Toxicology
Date 2017 Nov 30
PMID 29185196
Citations 5
Authors
Maryann Mazer-Amirshahi
Andrew Stolbach
Lewis S Nelson
Affiliations
Soon will be listed here.
Abstract

Antidotal therapy is an essential component of poisoning management. In recent years, there have been unprecedented increases in the costs of antidotes. The American College of Medical Toxicology calls upon providers, hospitals, formularies pharmaceutical industry, government, insurance companies, and pharmacy benefit managers to adopt practices to ensure that antidotes are available to our patients and price are based on value and cost.

Citing Articles

Trends in Reptile Holdings Across UK Zoos: Identification of the Factors Responsible for Declining Numbers of Venomous Snake.

Sparrow L, Gill I, Michaels C, Turner C Zoo Biol. 2024; 43(6):556-569.

PMID: 39286937 PMC: 11624627. DOI: 10.1002/zoo.21868.

Trends in Shortages of Lead Chelators From 2001 to 2022.

Whitledge J, Soto P, Glowacki K, Calello D, Fox E, Mazer-Amirshahi M J Pediatr Pharmacol Ther. 2024; 29(3):306-315.

PMID: 38863853 PMC: 11163907. DOI: 10.5863/1551-6776-29.3.306.

Drug Shortages Negatively Impact Health Systems and Bedside Patient Care.

Routsolias J, Webb A J Med Toxicol. 2023; 19(3):246-247.

PMID: 37266907 PMC: 10293503. DOI: 10.1007/s13181-023-00950-6.

Pharmaceutical Purchasing: a Review of the Landscape and Implications for Antidotal Therapies.

Troger A, Burns M J Med Toxicol. 2023; 19(3):262-267.

PMID: 37249803 PMC: 10293135. DOI: 10.1007/s13181-023-00943-5.

Benzodiazepine Shortages: A Recurrent Challenge in Need of a Solution.

Whitledge J, Fox E, Mazer-Amirshahi M J Med Toxicol. 2022; 19(1):4-6.

PMID: 36414791 DOI: 10.1007/s13181-022-00917-z.

References
1.
Dart R, Goldfrank L, Chyka P, Lotzer D, Woolf A, McNally J . Combined evidence-based literature analysis and consensus guidelines for stocking of emergency antidotes in the United States. Ann Emerg Med. 2000; 36(2):126-132. DOI: 10.1067/mem.2000.108182. View
2.
Kesselheim A, Avorn J, Sarpatwari A . The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform. JAMA. 2016; 316(8):858-71. DOI: 10.1001/jama.2016.11237. View
3.
Kantarjian H, Rajkumar S . Why are cancer drugs so expensive in the United States, and what are the solutions?. Mayo Clin Proc. 2015; 90(4):500-4. DOI: 10.1016/j.mayocp.2015.01.014. View
4.
Heindel G, Trella J, Osterhoudt K . Rising cost of antidotes in the U.S.: cost comparison from 2010 to 2015. Clin Toxicol (Phila). 2017; 55(5):360-363. DOI: 10.1080/15563650.2017.1286014. View
5.
Uhl K, Peters J, Flanagan K . High-cost generic drugs--implications for patients and policymakers. N Engl J Med. 2015; 372(7):685-6. DOI: 10.1056/NEJMc1415471. View